Business Description
IntelliPharmaCeutics International Inc
NAICS : 325412
SIC : 3741
ISIN : CA4581731011
Compare
Compare
Traded in other countries / regions
IPCI.H.CanadaI4AA.GermanyIPCIF.USA IPO Date
1996-08-07Description
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 81.01 | |||||
| 14-Day RSI | 71.27 | |||||
| 6-1 Month Momentum % | 200 | |||||
| 12-1 Month Momentum % | 282.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 13.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.35 | |||||
| EV-to-EBITDA | -2.5 | |||||
| EV-to-Revenue | 7.49 | |||||
| Earnings Yield (Greenblatt) % | -42.55 | |||||
| FCF Yield % | 1.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IPCIQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IntelliPharmaCeutics International Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.905 | ||
| EPS (TTM) ($) | -0.092 | ||
| Beta | 1.68 | ||
| Volatility % | 283.94 | ||
| 14-Day RSI | 71.27 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.15 | ||
| 12-1 Month Momentum % | 282.65 | ||
| 52-Week Range ($) | 0.0213 - 0.15 | ||
| Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IntelliPharmaCeutics International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IntelliPharmaCeutics International Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
IntelliPharmaCeutics International Inc Frequently Asked Questions
What is IntelliPharmaCeutics International Inc(IPCIQ)'s stock price today?
The current price of IPCIQ is $0.15. The 52 week high of IPCIQ is $0.15 and 52 week low is $0.02.
When is next earnings date of IntelliPharmaCeutics International Inc(IPCIQ)?
The next earnings date of IntelliPharmaCeutics International Inc(IPCIQ) is .
Does IntelliPharmaCeutics International Inc(IPCIQ) pay dividends? If so, how much?
IntelliPharmaCeutics International Inc(IPCIQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers